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In the field ofstructure-activity relationship
(SAR) studies, the software programs CASE
(computer-automated structure evaluation)
and MULTICASE, created by Klopman
and Rosenkranz (1), represent an original
approach for elucidating mechanisms of
interaction between biological systems and
exogenous compounds to predict the biolog-
ical activities of chemicals. The strategy
adopted is based on thehypothesis that mol-
ecular connectivity identifies the tridimen-
sional structure: fragments of connected
atoms and their interatomic bonds deter-
mine to a significant extent angles between
pairs of contiguous atoms and their inter-
atomic distance. The program should be
able to detect, with the help ofa statistical
procedure, the submolecular structures that
could interact with biological sites (i.e.,
receptors) involved in the biological process
analyzed. The structure can be responsible
for the biological activity ofthe compound
(biophore) or its inhibition (biophobe).
This view partially agrees with the work of
Ashby and Paton (2), who singled out spe-
cific molecular fragments associated with
genotoxicity.
The analytical capabilities of CASE
increase with the amount of data input.
CASE minimizes the possibility ofbias due
to human factors because it identifies para-
meters objectively, independent of human
judgment. The only human operations are
the choice of the data to be submitted to
analysis and the interpretation of data in
output. The selection of the descriptors
(molecular fragments) that are used to pre-
dict biological activity is completely auto-
mated. The choice ofdescriptors is based on
statistically significant prevalence in active
or inactive molecules.
Since 1984, many studies have been
published by Klopman and Rosenkranz
(3-11) on this subject: sets of congeneric
and noncongeneric compounds have been
tested for several biological endpoints
(mutagenicity, carcinogenicity, etc.). We
have selected for discussion in this report
some papers among the most pertinent to
our work. Concerning predictivity, the
results obtained by Klopman and Rosen-
kranzchange fordifferent endpoints and for
different chemical classes analyzed and over-
all show a high level of accuracy; often,
however, predictivity has been tested only in
the training set or in arbitrarily built test
sets.
The general strategy ofCASE is known,
but the detailed structure ofthe software is
not available because it is protected bycopy-
right. Up to now, all reports on predictivity
using CASE have been published solely by
the program creators orbyauthors using the
CASE program by license or permission.
Due to these restrictions, we saw the need
to develop a new, completely independent
program to confirm (or disprove) the validi-
ty of the type of SAR approach used by
CASE.
Our software uses graph theory to
reproduce basic operations characterizing
the CASE program. The program associates
a graph with a molecule to represent its
topological properties. The program search-
es forsubgraphs (molecularfragments) char-
acteristic of groups of carcinogenic or non-
carcinogenic compounds. To test the per-
formance of the software, we chose the
induction oftumors in rodents as a biologi-
cal endpoint. Tumors are the endpoint of
carcinogenesis, a complex multistage event,
in which genetic alterations are only one
part ofthe story. We used the Carcinogenic
Potency Database (CPDB) (12-15) and the
National Toxicology Program (NTP)
(16-18) data to obtain information on
rodent carcinogenicity. We divided the data
into two subsets: a randomly selected learn-
ing set including 80% ofthe chemicals, and
a nonoverlapping test set including 20% of
the chemicals. An additional control analy-
sis tested an artificially paired set of data
where carcinogenicity is attributed random-
ly to the molecules of the training set but
not to the molecules ofthe test set.
Methods
Software Features
To analyze the possible relationships
between the structure of molecular frag-
ments and carcinogenicity, our software
analyzes the topological properties ofmole-
cular fragments using graph theory. For a
detailed introduction to graph theory, see
Christofides (159).
Graph theory is used to relate the topo-
logical properties ofmolecules to their pos-
sible carcinogenicity. A graph is a pair (V,
E), where Vis the set {vi, i= 1,...n} ofver-
tices, and Eis the set {eij= (vi, v), vi, v; E
1/ of edges that express existing relations
between vertices; both vertices and edges
may be labeled (i.e., they may have an
associated name or value). Any compound
can be represented as a graph by associat-
ing the atoms with the vertices and the
bonds with the edges. This kind of repre-
sentation is frequently adopted in literature
because it allows easyhandling ofthe topo-
logical properties of compounds. In fact,
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graph theory has many applications, such
as in nomenclature, coding and informa-
tion processing, storage, and retrieval (20).
Our software system uses a fragmenta-
tion approach to determine whether sub-
families of compounds with carcinogenic
activity, or lack thereof, are characterized
by the presence ofsome common structur-
al features (molecular fragments). A similar
approach has already been applied in earli-
er computer-aided methods (21-23) for
predicting different biological activities
(antiarthritic-immunoregulatory effects
and antineoplastic effects). In these earlier
works, not all the possible fragments with-
in a given range of nonhydrogen atoms
were generated, but only a limited subset
of fragments, such as augmented atoms,
heteropaths, and ring fragments. A defini-
tion ofthese substructural units is given by
Chu et al. (22). Our work is mainly based
on the works ofRosenkranz and Klopman
(3,4) and on the studies ofAshby (24,25),
who has defined indicators that can be
thought of as subgraphs usually present in
genotoxic compounds (genotoxicity is an
important component ofcarcinogenicity).
Essentially, the system searches all the
fragments (i.e., subgraphs) of the com-
pounds present in the training set whose
activity is known, in an attempt to deter-
mine a reliable set of fragments whose
presence in compounds of unknown car-
cinogenicity (test set) may be an indicator
of their activity. In particular, the main
procedure ofthe program that executes the
fragmentation works as follows: all the
fragments within a given size ofeach com-
pound of the training set are produced; a
unique code is associated with any frag-
ment yielded, and, if this code is not
already present in a fragment dictionary, it
is inserted in the dictionary. A list of the
compounds to which the fragment belongs
is linked to the fragment code and it is ini-
tially filled with the code ofthe compound
currently examined. Otherwise, ifthe frag-
ment code is already present in the dictio-
nary, only the corresponding compound
list is updated. Once all the compounds of
the training set have been fragmented, the
system scans the dictionary by searching
for the fragments that satisfy the statistical
conditions (described in later).
The program was developed in stan-
dard C language, and it can be compiled
on both MS-DOS and Unix architecture.
The version used for the experiments
described here can run on any machine
with a 3.0 or later version of MS-DOS
operating system, and it requires at least 4
MB ofmemory and 100 MB ofhard disk.
A typical experiment (a single run of a
standard training set of 661 molecules)
takes about 4 hr ofcomputation time on a
486 machine to develop the database of
significant fragments. Two additional
hours are required for the statistical analy-
sis that selects the significant fragments.
The amount of time needed to determine
if a new compound of a test set contains
one or more of such fragments depends
mainly on the compound structure; for
example, the analysis ofa 40-atom (nonhy-
drogen) compound, normally connected,
takes about 5 min, whereas a 10-atom
(nonhydrogen) compound takes no more
than 30 sec.
The program accepts as input an
ASCII file describing the structure of the
compounds that will be analyzed by a con-
nectivity matrix. A separate interface pro-
gram has been developed to graphically
input such structures, storing them in that
ASCII file. In general, the analysis system
yields synoptic report files, but it also
stores information in ASCII files in which
data are organized in tables; in this way
such information can be easily accessed by
the most database software.
Statistical Methods
After the software has considered all the
molecular subunits with size between two
and eight "heavy" atoms, a statistical analy-
sis is performed to select only significant
fragments. The first selection is based on
the distribution of the fragments between
positive and nonpositive molecules. The
training set initially generates a global
number of about 278,000 fragments. Of
these, about 103,000 are different frag-
ments. For the successive stages of the
analysis, the software keeps only those frag-
ments that have a probability of random
association with carcinogenicity (or lack
thereof) lower than 0.125 (one tailed)
according to binomial distribution. We
computed our statistical estimate for the
tail in the direction of biological preva-
lence; however, statistical fluctuations can
make a fragment significant in both direc-
tions (carcinogenicity or lack thereof.
Therefore, conceptually, the real confi-
dence limits have to be considered two
tailed and about twice the one-tailed level
of confidence. We have calculated the
probability for the entire tail ofthe distrib-
ution to estimate statistical significance.
For each monomial ofthe distribution we
have used the classical formula:
Pr(X) =[X!(N-X)](p )(q )
where Nis the number oftimes in which a
given fragment has been generated in dif-
ferent molecules (trials); Xis the number
of times in which the fragment has been
generated bypositive molecules (successes);
p is the probability that one fragment has
been generated by a positive molecule
(probability of success); its value is deter-
mined by the ratio
p fragmentsgeneratedbypositivechemicals (_ 159,000)
fragmentsgeneratedbyallchemicals (_278,000)
q is the probability that the fragment has
been generated by a nonpositive molecule
(probability offailure = 1 -p); and Pr(X) is
the probability of X successes (single
monomial).
The fragments selected in this way are
labeled "activating" if their occurrence in
carcinogenic chemicals is higher than the
statistical limit that we established. Sim-
ilarly, the fragments are labeled "inactivat-
ing" if their occurrence in nonpositive
compounds is higher than the established
statistical limit. In a second stage, the pro-
gram removes the fragments that are
redundant because they are "imbedded" in
larger fragments and have identical behav-
ior (only the subunit with smaller size is
kept). At this stage the number of frag-
ments is reduced at least 300 times in
respect to the initial set offragments gener-
ated (generally from 103,000 to 315 frag-
ments).
A test set, a random sample ofthe over-
all data set, is tested to search each chemi-
cal for the presence ofsignificant fragments
selected in the training stage. On the basis
of fragment distribution for the chemicals
in the test set, a prediction oftheir carcino-
genicity is made.
A molecule ofthe test set can have one
or more fragments that are present in mol-
ecules of the training set. Combining the
statistical significance of these fragments,
we calculate an empirical index, PI (proba-
bility index), for the molecules of the test
set. An example of the calculation of this
simple index follows.
A molecule, Xv, ofthe test set contains
three fragments among those ones selected
as statistically significant in the training set
(Fl and F2 "activating," F3 "inactivating").
The fragment Fl has been selected because
it is present, in the training set, in five
active molecules (AT, BT, CT, DT, ET) and
in one inactive molecule (GT). Similarly,
F2 is contained in four active molecules
(AT, BT, CT, HT), whereas the selection of
fragment F3 originates by the presence of
this subunit in four inactive molecules
(GT, QT' ST, TT). The fragments F1 and
F2 are probably related because they were
generated by a similar set ofmolecules. To
remove the redundancies, the two frag-
ments are treated as one fragment that
originates by seven chemicals (AT, BT, CT,
DT' ET, GT' HT). In a similar way, the
information obtained from the fragments
F3 is added to create a single aggregate (AT,
BT, CT, DT, ET' GT, HT, QT' ST, TT), in
which the ratio between molecules with
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Figure 2. Distribution of probability indexvaluesforthe chemicals in the average training set.
carcinogenic properties and all the mole-
cules contributing to the evaluation is 0.6.
This value is used as a PI.
A successive step is the calculation of
the PI value that is used as a cut-offvalue
to define two categories (positives and neg-
atives) ofpredicted activity for the test set.
This cut-off index is the value that maxi-
mizes the accuracy ofthe contingency table
2 x 2 (carcinogenicity or lack thereof ver-
sus predicted activity) in the training set.
Accuracy in the training set as a function
ofthe PI is illustrated in Figure 1. Levels of
accuracy higher than 0.73 are obtained in
the training set in a range of PI values
between 0.35 and 0.8. This is because the
majority of molecules have a probability
index higher than 0.8 or lower than 0.35
(Fig. 2). A cut-off within this range only
slightly affects the attribution to the car-
cinogenic or noncarcinogenic class. The
average optimal cut-offvalue for eight runs
was 0.41.
Preliminary runs ofour program show-
ed, for partial subsets of carcinogenicity
data, statistical fluctuations in terms ofpre-
dictivity indices. For this reason, we per-
formed eight runs using our final database
(826 compounds, 515 carcinogens and
311 noncarcinogens). For each run we
randomly drew 80% ofcompounds for the
training set and used the remaining 20% as
the test set. We also performed eight
paired runs using the same chemicals, but,
in this case, the property ofcarcinogenicity
in the training set was randomly attributed
(pseudo-training set). The procedure for
randomly selecting the chemicals for the
training set and the test set imposed the
condition that in both sets, 62.3% of the
chemicals must be positive carcinogens.
This simple procedure uses a routine of
BASIC language (RANDOMIZE TIMER)
as a random-number generator to assign
the chemicals for the training sets and to
assign the carcinogenic property in the
pseudo-training sets.
To evaluate the predictivity level ofour
methodology, we adopted some indices that
are conventionally used for diagnostic tests:
Sensitivity (SE) = [TP/(TP+FN)]100
Specificity (SP) = [TN/(TN+FP)]100
Positive predictive value (PPV) =
[TP/(TP+FP)]100
Negative predictive value (NPV) =
[TN/(TN+FN)] 100
Observed correct predictions (OCP) =
[(TP+TN)/AM100
where TP = true positive, FP = false posi-
tive, TN = true negative, FN = false nega-
tive, and N = (TP + FP + TN + FN) =
number ofmolecules in the data set.
In addition, according to Klopman and
Kolossvary (26), we evaluated the follow-
ing two parameters:
Expected correct predictions
(ECP) = (1 + 2 * X* Y-X- Y)100
where Xis the fraction ofactive molecules
in the data set, and Yis the fraction of
molecules predicted as active.
N +~FN
+
X(TP+FP)(TP+FN) (FN+TN)(FP+TN)
FP2 FN2
(TP+FP)(FP+TN) (FN+TN)(TP+FN)
Sources ofData
We gathered the carcinogenicity data ana-
lyzed here from two ofthe main databases:
CPDB (12-15), in which more than 4000
experimental values are reported (1053
chemicals are considered in the database),
and the NTP database (16-18), in which
301 chemicals have been tested with stan-
dardized protocols in mice and rats. The
two databases provide qualitative and
quantitative data for each experiment. We
considered only qualitative results because
our software can process only categorical
outcomes at this time. To simplify the sit-
uation, in our first analysis we used only
binary data: we classified the experimental
results for each chemical as "positive" or
"nonpositive." To this end, we arbitrarily
fixed criteria to make a binary outcome.
Table 1 shows the rules adopted for
CPDB data, and Table 2 describes the
rules used for NTP data. The two databas-
es overlap extensively due to the fact that
NTP data (except for most recent experi-
ments) are already contained in CPDB.
For only a few chemicals was there incom-
plete agreement between the two sources:
Table 3 considers all the possible combi-
nations ofmatched results.
A large portion of the compounds for
which there are data available in the two
databases is included in our database. No
intentional selection was performed. We
discarded 50 (4.4%) chemicals with un-
certain carcinogenicity status (not classified
according to Tables 1-3); 263 (23.1%)
chemicals were excluded for one or more
of the following reasons: 1) administered
in mixture; 2) less than three "heavy"
atoms; 3) molecules too large for the input
interface (more than 50 heavy atoms); 4)
contained unusual atoms (chemicals con-
taining only H, C, S, N, Cl, 0, Na, F, Br,
P were included in the database); 5) diffi-
culty finding the structural formula. Our
program can currently analyze 826 chemi-
cals. The CAS numbers ofthese chemicals
are given inAppendix A.
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Results
The fragmentation stage of the process
produces about 278,000 fragments (aver-
age of8 runs), adding up all the fragments
produced for each molecule; of these,
about 103,000 are different fragments.
From the analysis-of their occurrence and
after removal of redundant fragments, on
the average, 315 fragments significantly
associated with carcinogenicity or lack
thereof (p<O.125 according to binomial
distribution) are kept for the successive
steps of the analysis. The number of frag-
ments is significantly lower for the paired
training sets with a random attribution of
carcinogenicity: on average, 174 fragments
are selected. Detailed features of the data
analyzed are summarized in Table 4. We
also counted the fragments generated with
a threshold of statistical significance at
p<O.Ol. In this case, the training set of all
the 826 chemicals in our database generat-
ed 50 fragments, whereas 6 pseudo-train-
ing sets (see Methods) of 826 chemicals
generated an average of only 11.8 frag-
ments. Examining the distribution of the
fragments shown in Appendix B, we ob-
serve that the most common size is 4 heavy
atoms (15 fragments), although sizes
between 3 and 7 are also relatively com-
mon (5-10 fragments). Only two signifi-
cant fragments of eight heavy atoms and
only one fragment of two heavy atoms are
present.
The 315 fragments obtained from the
training stage are prevalently "inactivat-
ing" (60.6%), and only 39.4% are "acti-
vating." This fact may be due to the ratio
between fragments generated from car-
cinogens and noncarcinogens in the data-
base studied. In our global database we
have more carcinogens (62.3%) than non-
carcinogens (37.7%). However, noncar-
cinogens have an average size larger than
carcinogens (15.1 heavy atoms versus 13.0
heavy atoms). Most likely for this reason,
out ofthe total number ofgenerated frag-
ments (redundant fragments included),
57.0% come from carcinogens and 43.%
from noncarcinogens. Figure 3 shows the
distribution ofthe occurrences of 103,000
fragments of the average training set. In
the case of negative fragments, those pre-
sent in three noncarcinogens reach our
established limit of statistical significance
(0.433<0.125). This is not the case for
positive fragments (0.573>0.125). For a
positive fragment to become significant, it
has to be wresent in at least four carcino-
gens (0.57 <0.125). As shown in Figure 3,
many more fragments are present at least
three times than those present at least four
times. Statistically significant negative
fragments can be sorted from a larger set
than statistically significant positive ones.
As a consequence, even if we start with
Table 1. Criteria used to define categories of carcinogenicity: CPDB data
Statistical significance Authors' opinion" Categoryb
p>0.l -, NE NP
e,p,a,c,+ NC
O.1>p>O.01 NP
e,p,a,NE NC
c,+ P
p<O.O1 NP
e,p NC
a,c,+,NE P
These notations are used in the CPDB (13): a, National Cancer Institute (NCI) or NTP evaluation is that
the incidence of tumors at thatsite(s) was associated with administration ofthe compound. This code is
used for technical reports before March 1986; c, NTP evaluation is clear evidence of carcinogenic
activity. For NCI/NTP reports before March 1986, c indicates that the evaluation was carcinogenic; e,
NTP evaluation is equivocal evidence of carcinogenic activity: studies that are interpreted as showing a
marginal increase of neoplasms that may be chemically related; p, NTP evaluation is some evidence of
carcinogenic activity: studies that are interpreted as showing a chemically related increased incidence
of neoplasms (malignant, benign, or combined) in which the strength of the response is less than that
required for clear evidence; +, author in general literature evaluated site as positive;-, in the general lit-
erature the author evaluated site as negative. NTP evaluation is no evidence of carcinogenic activity:
studies that are interpreted as showing no chemically related increases in malignant or benign neo-
plasms; NE, no evaluation for NTP and general literature.
bp, positive; NC, not classified; NP, nonpositive. A chemical that could be defined as positive at least in
a single species, in a single sex, in a single site, was defined as positive. A chemical that could be
defined as nonpositive in all sites was defined as nonpositive. Chemicals with a mixture of not classified
and nonpositive evaluations were discarded as equivocal.
Table 2. Criteria used to define categories of
carcinogenicity: NTP data
Class' Category"
A,B,C,D P
E NC
F NP
aThese notations are used in the NTP database to
define the effect across the species, sexes, and
tissues (17): A, carcinogenic in both species; B,
carcinogenic in single species with two or more
tissues affected; C, carcinogenic in single spec-
ies with a single tissue affected; D, carcinogenic
in single sex of a single species with a single tis-
sue affected; E, equivocal study providing equivo-
cal evidence of carcinogenicity; F, chemical
associated with noncarcinogenicity.
bp, positive; NC, not classified; NP, nonpositive.
more positive (57%) than negative frag-
ments (43%), we end up with 60.6% sta-
tistically significant negative fragments
and 39.4% statistically significant positive
ones (in the final set of 315 statistically
significant different and nonredundant
fragments).
Among the 315 significant and nonre-
dundant fragments, similar (not identical),
related fragments are still present, but the
possible bias that they could introduce in
terms ofpredictivity is lessened by the sta-
tistical treatment described in the previous
section. These fragments generate the pre-
dictions of carcinogenicity or lack thereof
for the test sets. For each run, a 2 x 2 con-
tingency table is created and all the most
important indices ofqualitative predictivi-
ty are calculated.
Table 3. Criteria used to define categories of car-
cinogenicity: possible overlapping
CPDB status NTP status Category'
P P P
p NC P
P NP P
NC P P
NC NC NC
NC NP NP
NP P P
NP NC NP
NP NP NP
ap, positive; NC, not classified; NP, nonpositive.
Table 4. Detailed features of the training sets
(average of eightruns)
Number of compounds 661
Percentage of positive compounds 62.3
Total fragments generated 277,723
Percentage of positive fragments 57.1 (62.7)8
Total differentfragments generated 103,490
Statistically significantfragments 315(174)8
(after removal ofredundance)
Percentage of positive fragments 39.4(37.5)8
aAverage value of the eight paired runs with
carcinogenicity randomly attributed.
Table 5 shows the contingency table
obtained from the average data ofeight runs
for the compounds in the training sets
where real experimental carcinogenicity data
have been used. All the indices calculated
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Carcinogens Noncarcinogens Total
Predicted positives 267.6 39.5 307.1
Predicted negatives 45.9 168.6 214.5
Total 313.5 208.1 521.6
Sensitivity 85.4%
Specificity 81.0%
Positive predictive value 87.1%
Negative predictive value 78.6%
Expected correct predictionsa 51.8%
Observed correct predictions 83.6% (±0.38)
x 227.7(p<10-)
Carcinogenicity attributed according toTables 1-3; average of eight runs (± SE).
aAs defined in Klopman and Kolossvary (26).
Table6. Software prediction forthetraining sets
Carcinogens Noncarcinogens Total
Predicted positives 157.9 18.5 176.4
Predicted negatives 60.3 140.3 200.6
Total 218.2 158.8 376.9
Sensitivity 72.4%
Specificity 88.3%
Positive predictive value 89.5%
Negative predictive value 69.9%
Expected correct predictionsa 49.5%
Observed correct predictions 79.1% (±2.04)
x2 136.0(p< 10-6)
Carcinogenicity randomly attributed; average ofeight runs (±SE).
aAs defined in Klopman and Kolossvary (26).
Table 7. Software prediction forthe test sets
Carcinogens Noncarcinogens Total
Predicted positives 58.9 23.3 82.1
Predicted negatives 17.9 26.5 44.4
Total 76.8 49.8 126.5
Sensitivity 76.7%
Specificity 53.3%
Positive predictive value 71.7%
Negative predictive value 59.7%
Expected correct predictions 53.2%
Observed correct predictions 67.5% (± 1.32)
X2 11.9(p<0.0006)
Carcinogenicity attributed according to Tables 1-3; average of eight runs (± SE).
aAs defined in Klopman and Kolossvary(26).
Table B. Software prediction forthe testsets
Carcinogens Noncarcinogens Total
Predicted positives 30.1 21.0 51.1
Predicted negatives 29.0 20.0 49.0
Total 59.1 41.0 100.1
Sensitivity 50.9%
Specificity 48.8%
Positive predictive value 58.9%
Negative predictive value 40.8%
Expected correctpredictions 50.2%
Observed correctpredictions 50.1% (±1.95)
x2 0.00 (p <1)
Carcinogenicity randomly attributed (inthetraining sets); average ofeight runs(±SE).
'As defined in Klopman and Kolossvary (26).
seem to show a high level of predictivity.
However, even the indices obtained with
the eight training sets where carcinogenici-
ty was randomly attributed (Table 6) show
a high predictivity performance. It is clear
that the results obtained are not due to the
predictive capability of the program but
mainly to the many degrees of freedom
existing in the system. These degrees of
freedom allow for an aposterioriadaptation
of the program to the pattern of positive
and negative data in the training sets. In
conclusion, the training sets cannot be
used for an assessment of predictivity. It
must be noted that the pseudo-training
sets generate less "significant" fragments
than the real training sets. As a conse-
quence, there are fewer chemicals associat-
ed with a positive or negative prediction
(376.9) in respect to the real training sets
(521.6).
Table 7 shows the contingency table
obtained for an average of eight test sets.
The level of accuracy (67.5%) is signifi-
cantly higher (p-0.0006) than the expected
level, based on the hypothesis ofno associ-
ation between connectivity and carcino-
genicity (53.2%). The results obtained
when the training sets with carcinogenicity
randomly attributed are used to predict the
same test sets (Table 8) do not show any
association. These results and the previous
observation that for a random attribution
ofcarcinogenicity, about 55% ofapparent-
ly significant fragments are generated in
respect to a real training set, strongly sug-
gest that connectivity is associated only
with a real biological property and not
with a randomly distributed simulated
property.
Among the 165 chemicals of the test
sets: 1) 32.4% (average ofeight runs) con-
tained only statistically significant positive
fragments and were predicted with an
accuracy of78.7%; 2) 24.4% ofthe chem-
icals contained only statistically significant
negative fragments and were predicted
with an accuracy of60%; 3) 19.8% ofthe
chemicals contained both statistically sig-
nificant positive and negative fragments
and were predicted with an accuracy of
59.3%; 4) 23.3% of the chemicals con-
tained no statistically significant fragments
(70.8% of these chemicals were carcino-
gens and 29.2% were noncarcinogens),
thus preventing a prediction of carcino-
genicity.
Ofthose chemicals without statistically
significant fragments, the ratio between
carcinogens and noncarcinogens (70.8/29.2)
is higher than the ratio present in the glob-
al database (62.3/37.7). This result can be
explained by the fact that among the 315
statistically significant fragments selected
by the program, more negative fragments
(60.6%) than positive fragments (39.4%)
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are detected. For this reason, perhaps, we
more often detected noncarcinogens than
carcinogens. This could explain the enrich-
ment in carcinogens among the molecules
not associated with significant fragments.
Discussion
The major drawback to this type of auto-
mated analysis is the number ofelementary
operations performed and the quantity of
memory needed. Determining the largest
common subgraph between two graphs is a
nonpolynomial task and requires time that
exponentially depends on the size of the
graphs and subgraphs involved. For-
tunately, some characteristics ofthe chemi-
cal compounds partially simplify this oth-
erwise formidable task: 1) the maximum
number of edges converging at a node is
usually small (around four); 2) the number
ofatoms in the compounds ofour database
is relatively small: the average number of
heavy atoms (nonhydrogen) per com-
pound is 13.8, and the largest compound
contains 48 heavy atoms (see Fig. 4); 3)
the maximum size of the searched frag-
ments was limited to eight heavy atoms. As
can be observed in Figures 5 and 6, frag-
ments of greater size tend to appear in
large numbers, but each ofthem tend to be
present in too few compounds to be statis-
tically significant. We have also observed
that in our database, the information (asso-
ciated with carcinogenicity or lack thereof)
related to fragments ofsize 9 is redundant
in respect to the information of smaller
sizes in 100% ofthe cases (data not report-
ed).
Finally, thus far, the adopted technique
of representation of molecular fragments
does not make a distinction among steric
isomers; such cases will be dealt with in a
future improvement to the system.
We have described the method for cal-
culating our PI value in Methods. We used
the PI value as a discriminant for deciding if
a molecule ofthe test set will be predicted to
be a carcinogen or a noncarcinogen. The
strategy adopted prevents strongly related
fragments from contributing to the analysis
as independent fragments. In this way the
informative content of a single chemical in
the training set can have only one unit
weight: we thus avoid the introduction ofa
bias ofredundancy resulting from the mul-
tiplication ofinformation related to a single
molecule.
This strategy can introduce a different
potential bias for a subset ofmolecules with
different active substructures all common to
the same molecules: in this case the index
calculated can be underestimated. However,
in our opinion, adding up the contributions
ofhighly correlated fragments would cause
more distortion than discarding multiple
contributions present in the same molecule.
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As a general result, we have confirmed
what has been suggested by Klopman and
Rosenkranz (4): an approach based on
molecular connectivity can predict carcino-
genicity. The results obtained in our test
sets are statistically significant (p-0.0006).
We believe that the observed levels ofpre-
dictivity are not only statistically signifi-
cant but also biologically relevant and
potentially useful as one component of a
spectrum of information that can con-
tribute to hazard evaluations. Our initial
work is promising, but we must test the
software in additional experiments to
develop it as a predictive toxicology sys-
tem. For instance, we have to investigate
in detail the performance of our program
for different thresholds ofstatistical signifi-
cance when we are selecting significant
fragments from the training set to be used
for predictions in the test set.
We can logically presume that with a
smaller (and/or less diversified) training
set, a fragment potentially associated with
carcinogenicity or lack thereof could not
reach statistical significance (or reach a
more equivocal statistical significance).
Therefore, we would expect that the per-
centage of nonassessable chemicals should
decrease for a larger training set, and we
should obtain better predictivity in gener-
al.
We plan to test our software program
using smaller training sets (i.e., from 200
to 400 chemicals randomly selected) to
verify if our assumption is correct. Klop-
man and Rosenkranz (11) have already
verified this assumption. However, for the
moment, we do not know ifthe similarities
between the CASE program and our pro-
gram are sufficient to allow extrapolation
of their results to the results of our pro-
gram.
We also have to look in detail at the
fragments selected as significant to com-
ment about their biological plausibility and
compare them with the alert structures of
Ashby (2,16,17,18,24,25) and also with
fragments identified by the CASE and
MULTICASE programs. We plan to coor-
dinate with the authors of CASE and
MULTICASE to test our respective pro-
grams with identical training sets and iden-
tical test sets so that we can compare the
results obtained.
We used a database much larger than
those used previously by other authors. We
have obtained an average (eight runs) level
ofaccuracy of67.5% (SE, ±1.3). As shown
in Table 7, we predicted 82.1 chemicals as
positive and 44.4 as negatives. Ifthese pre-
dictions (with the same proportions ofpre-
dicted positives and negatives) had been
based only on chance, the level ofaccuracy
would have been 53.2% (ECP value). In
our database, the prevalence of positive
carcinogens is 62.3%. If we had predicted
all the chemicals ofthe test sets as carcino-
gens, we would have obtained an accuracy
of 62.3%. When you predict that all
chemicals are potential carcinogens, the
sensitivity is 100% and the specificity is
0%, and the prediction is not very useful.
An accuracy of 62.3% is apparently not
very different from 67.5%, but we would
anticipate for our software program levels
of accuracy in the range of 65-70% at a
ratio of carcinogens/noncarcinogens of
50/50, or even 38/62. We plan to perform
these experiments in a future study.
Different levels of predictivity were
observed for different subclasses of chemi-
cals. For instance, the confidence of the
prediction for a chemical of the test sets,
characterized only by positive fragments, is
significantly higher (78.7%) than the con-
fidence of the prediction for a chemical
characterized only by negative fragments or
contradictory fragments (60.7% and 59.3%,
respectively).
We have met some difficulties in per-
forming a direct comparison ofour results
with the results obtained by CASE. At the
level ofthe training set, accuracy was high-
er (95%) for CASE (8,9) than for our
program. This difference is probably relat-
ed to differences in the decisional-statistical
procedures used for the information ob-
tained from different molecular fragments.
In addition, the carcinogenicity database
used by Klopman and Rosenkranz was dif-
ferent from ours. We have clearly demon-
strated that accuracy at the level of the
training sets is not correlated to the real
predictivity ofthe software program (com-
pare Tables 6 and 8).
A test set concerning carcinogenicity is
present in two different reports by Klop-
man and Rosenkranz (8,9). The training
set contained 189 chemicals of the NTP
study (50.2% active, 22.2% marginally
active, and 27.5% noncarcinogens). The
rodent carcinogens (or noncarcinogens)
considered in the test sets ofthe two papers
are the same chemicals. They had been
evaluated for carcinogenicity in the
GeneTox program. In this test set, 23 out
of 24 chemicals were rodent carcinogens.
The expected correct predictivity was 92%,
and the observed predictivity (accuracy)
was 100%. Obviously, it is not possible to
directly compare this extremely unbal-
anced database with ours.
In 1990, an analysis ofthe capability of
CASE to predict carcinogenicity for a
group ofpolycyclic aromatic hydrocarbons
was reported by Richard and Woo (27).
Thirty-one active and 25 inactive PAHs
were used in the training set ("LEARN"),
and 9 active and 15 inactive PAHs were
used in the test set ("VALIDATE"). The
authors reported an accuracy of 75% (SE,
89%; SP, 67%). In a recent publication
(28), results concerning the predictive
capabilities of CASE were reported for a
group ofchemicals for which carcinogenic-
ity data recently became available (NTP
studies). Out of25 chemicals predicted by
CASE, 17 were carcinogens and 8 were
noncarcinogens (6 equivocals omitted).
The degree of accuracy was 64% (SE,
59%; SP, 75%). Obviously, these results
are from a small test set, not directly com-
parable with ours.
Among the works published by Klop-
man and Rosenkranz, a larger database
(more similar to our database) was used to
predict mutagenicity in Salmonella. In a
recent study (1), Klopman and Rosenkranz
used mutagenicity data from the GeneTox
program and NTP studies to perform the
analysis. The training set was built using
GeneTox mutagenicity data, and the test
set was built using NTP mutagenicity data.
Chemicals present in both the databases
were not submitted to CASE and MULTI-
CASE analysis. In this way, the training set
contained 450 mutagens, 253 marginally
active mutagens, and 123 nonmutagens,
whereas the test set contained 63 muta-
gens, 21 marginally active mutagens, and
61 nonmutagens. The highest level ofpre-
dictivity obtained using the MULTICASE
program was about 80%, opposed to an
expected correct prediction ofabout 50%.
According to Ashby and Tennant (29),
mainly electrophiles (directly or after meta-
bolic activation) are involved in Salmonella
mutagenicity. It is reasonable to think that
mutagenicity in Salmonella should be more
easy to predict than the complex endpoint
of carcinogenicity: phenomena such as
promotion, clonal expansion, remodeling,
tissue necrosis and regeneration, and mod-
ulation ofproliferation, apoptosis, and dif-
ferentiation are clearly involved in the car-
cinogenic process, but not in mutagenicity
in Salmonella or in other short-term tests
of genotoxicity. We would expect a wider
and more heterogeneous spectrum of mol-
ecular fragments to be involved in carcino-
genicity than in genotoxicity. In the
future, we will have to apply our software
program not only to carcinogenicity but
also to mutagenicity in Salmonella to test
our hypothesis that it is in general easier to
predict genotoxicity than carcinogenicity.
After analyzing recent studies evaluat-
ing the qualitative correlation between
short-term tests for genotoxicity and car-
cinogenicity (30,31), we conclude that
accuracy is in the range of 56-62%. It
seems reasonable that short-term genotoxi-
city tests can reflect irreversible alterations
in the genome during carcinogenesis. On
the other hand, short-term tests should not
be able to monitor nongenotoxic events
(for instance, those events linked to pro-
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motion and clonal expansion of preneo-
plastic cells). The fact that the predictivity
ofmolecular connectivity is better than the
predictivity ofshort-term genotoxicity tests
suggests that molecular connectivity can
detect not only electrophilic fragments,
like the ones described by Ashby et al.
(2,16-18,24,25), but also fragments linked
to nongenotoxic effects (promotion, mod-
ulation ofdifferentiation, etc.). An alterna-
tive explanation of this difference in accu-
racy could be related to the fact that
nongenotoxic carcinogens may be more
abundant in the databases used to assess
the predictivity ofshort-term tests (30,31)
than in our larger database. In the future
we will investigate the predictivity ofmole-
cular connectivity for genotoxic and non-
genotoxic carcinogens.
We have discussed the predictive capa-
bility of short-term genotoxicity tests.
How much higher would this predictivity
be with a test biologically closer to carcino-
genicity in rodents? We can partially
answer this question. The endpoint ofcar-
cinogenicity in a single species of small
rodents is not very different in the evolu-
tionary scale from the endpoint ofcarcino-
genicity in at least one oftwo closely relat-
ed species. If our endpoint is now only in
mice or rats, we can predict carcinogenicity
in one species with carcinogenicity in the
other. For the database of Gold et al.
(12-15), a concordance of 75% between
rat and mouse studies has been reported
(32), and for the chemicals of the NTP
studies, a concordance of 74% has been
reported (33); the predictivity ofmolecular
connectivity is only moderately lower than
the values reported above. This can be con-
sidered an additional indication of the
good behavior of our parameter. We will
have to confirm this impression in future
experiments using only mouse data or rat
data.
Within the framework ofhazard evalu-
ation, we believe that the computerized
SAR approach should be given a weight
similar to that ofa standard short-term test
in a multifactorial analysis of the carcino-
genic potential of a given chemical. With
regard to genotoxicity and carcinogenicity,
Ashby (34) has pointed out that some frag-
ments detected as significant by Klopman
and Rosenkranz (and likewise by us) could
not stand an in-depth analysis performed
by a human expert, considering both bio-
logical and chemical specific arguments.
We agree with this observation. Because
we found in the pseudo-training sets a
number ofapparently significant fragments
equal to about 55% ofthe statistically sig-
nificant fragments found in the real train-
ing sets, we suspect that (as a first approxi-
mation) about half of the fragments de-
fined as significant according to our statis-
tical threshold (p<O.125, one tailed) are
spurious. According to our analysis, only
about 50% of apparently significant frag-
ments emerging from a training set can be
fragments of real biological significance.
The remaining 50% is probably generated
by chance and can also be present in a
pseudo-training set in which carcinogenici-
ty is assigned randomly. The level of pre-
dictivity reached in our experiments is
probably due to a mixture ofapproximate-
ly 50% predictive fragments and approxi-
mately 50% ofnoise fragments. We think
that fragments suggested as significant by
our software program should be considered
only as candidates for biological signifi-
cance, but are by no means foolproofbio-
logical indicators of carcinogenicity. Their
probability ofbeing significant is higher, as
expected, when we select a more severe sta-
tistical threshold. As a consequence of
these considerations, a new potentially sig-
nificant fragment detected by our software
program is only submitted to the attention
ofinvestigators as a possible fragment char-
acterizing a subfamily ofmolecules, poten-
tially responsible for their common car-
cinogenic activity. Additional biological
and chemical considerations could lead to
the acceptance or rejection ofthe fragment
as biologically significant. For instance, if
the chemicals considered are similar pro-
carcinogens, a similar metabolism should
generate similar proximate carcinogens and
perhaps also similar DNAadducts.
There are also cases in which it is
impossible to reach a definite conclusion.
Statistical significance is only one factor;
however, when the statistical threshold is
much more severe (p<0.01 instead of
p<0.125), the number of significant frag-
ments generated in a real training set is
four to five times larger than the number
of significant fragments generated in a
pseudo-training set (against a ratio of 2/1
for the threshold, p<0.125). Fragments
with a higher statistical significance deserve
priority in subsequent biological investiga-
tions with the aim of confirming or dis-
proving the existence of a new molecular
structure relevant for carcinogenicity or
genotoxicity. On the otherhand, the infor-
mation obtained with the threshold
p<0.125, while less significant than the
information obtained with the threshold
p<0.01, still allowed us to make predic-
tions about a much larger fraction of
chemicals. For this reason, the threshold
p<0.125 was selected for the general pre-
dictivitystudypresented here.
We have used the overall evidence of
carcinogenicity in at least one species, one
sex, and one tissue, without any considera-
tion about carcinogenic potency to deter-
mine whether or not a chemical is a car-
cinogen (yes or no). In the future we plan
to stratify our database according to spec-
trum of carcinogenicity (large spectrum,
narrow spectrum), as suggested by Ten-
nant (35) and perhaps take into considera-
tion different ranges ofpotency. A subfam-
ily ofchemicals sharing a common chemi-
cal fragment could also display a relatively
homogeneous behavior in respect to a dif-
ferent subfamily sharing a different frag-
ment.
Finally, in conclusion, we have con-
firmed that with a large database, using an
independent software program, SAR ap-
proaches based on the computer-automat-
ed detection ofmolecular fragments statis-
tically associated with a given biological
property can be used to predict carcino-
genicity in rodents. We are not aware of
other independent validations of this type
ofSARapproach.
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50-06-6 60-80-0 79-46-9 96-45-7 108-60-1 132-27-4 443-48-1 628-36-4 1836-75-5 5036-03-3 16699-10-8 39801-14-4
50-07-7 61-76-7 80-08-0 97-00-7 108-78-1 132-98-9 471-29-4 628-94-4 1867-73-8 5131-60-2 16813-36-8 40548-68-3
50-18-0 61-82-5 80-33-1 97-16-5 108-88-3 133-06-2 443-72-1 630-20-6 1897-45-6 5164-11-4 17026-81-2 40580-89-0
50-23-7 61-94-9 80-62-6 97-18-7 108-95-2 133-07-3 446-86-6 632-99-5 1912-24-9 5208-87-7 17157-48-1 42011-48-3
50-24-8 62-44-2 81-07-2 97-56-3 109-69-3 133-90-4 470-82-6 634-93-5 1934-21-0 5307-14-2 17608-59-2 42579-28-2
50-29-3 62-53-3 81-16-3 97-59-6 109-84-2 134-29-2 474-25-9 636-21-5 1936-15-8 5461-85-8 17673-25-5 43054-45-1
50-32-8 62-54-4 82-28-0 97-74-5 110-44-1 134-72-5 477-30-5 636-23-7 1955-45-9 5800-19-1 17924-92-4 51325-35-0
50-33-9 62-55-5 82-68-8 97-77-8 110-57-6 135-20-6 488-41-5 636-79-3 2104-09-8 5834-17-3 18413-14-4 51410-44-7
50-44-2 62-56-6 83-59-0 98-01-1 110-85-0 135-23-9 493-78-7 637-07-0 2113-61-3 5979-28-2 18523-69-8 51542-33-7
50-55-5 62-73-7 83-79-4 98-85-1 110-89-4 135-88-6 504-88-1 671-16-9 2122-86-3 5989-27-5 18559-94-9 51630-58-1
50-78-2 62-75-9 84-65-1 98-92-0 111-44-4 136-40-3 509-14-8 683-50-1 2163-79-3 6109-97-3 18662-53-8 51786-53-9
50-81-7 63-25-2 85-44-9 98-96-4 111-46-6 137-17-7 510-15-6 712-68-5 2164-09-2 6119-92-2 18883-66-4 52207-83-7
51-03-6 63-92-3 85-68-7 99-30-9 112-27-6 137-26-8 512-56-1 720-69-4 2185-92-4 6120-10-1 18968-99-5 52214-84-3
51-21-8 64-17-5 86-06-2 99-55-8 113-92-8 139-05-9 513-37-1 756-79-6 2227-13-6 6151-25-3 19767-45-4 53609-64-6
51-28-5 64-75-5 86-29-3 99-56-9 114-83-0 139-13-9 517-28-2 758-17-8 2243-62-1 6294-89-9 19834-02-7 53757-28-1
51-55-8 64-77-7 86-30-6 99-57-0 114-86-3 139-40-2 518-75-2 759-73-9 2302-84-3 6334-11-8 20265-96-7 54143-56-5
51-75-2 66-05-7 86-50-0 99-59-2 115-02-6 139-61-1 520-18-3 760-60-1 2303-16-4 6358-85-6 20325-40-0 54150-69-5
51-79-6 66-27-3 86-57-7 100-00-5 115-07-1 139-94-6 520-45-6 765-34-4 2318-18-5 6369-59-1 20570-96-1 54749-90-5
52-24-4 67-20-9 86-74-8 100-40-3 115-28-6 140-11-4 525-66-6 772-43-0 2425-06-1 6373-74-6 20917-49-1 55090-44-3
53-19-0 67-21-0 86-86-2 100-41-4 115-29-7 140-49-8 531-06-6 785-30-8 2432-99-7 6381-77-7 21308-79-2 55268-74-1
53-70-3 67-48-1 86-87-3 100-42-5 115-32-2 140-56-7 531-18-0 828-00-2 2438-88-2 6385-58-6 21340-68-1 55556-92-8
53-95-2 67-52-7 86-88-4 100-44-7 115-96-8 140-57-8 531-82-8 834-28-6 2439-10-3 6452-73-9 21416-87-5 55557-00-1
53-96-3 67-66-3 87-29-6 100-51-6 116-06-3 140-67-0 531-85-1 838-88-0 2465-27-2 6959-47-3 21436-96-4 55567-81-2
54-11-5 67-72-1 87-51-4 100-52-7 116-29-0 140-79-4 532-32-1 842-00-2 2475-45-8 6959-48-4 21436-97-5 55738-54-0
54-12-6 67-98-1 87-56-9 100-63-0 117-10-2 140-88-5 536-33-4 842-07-9 2489-77-2 6965-71-5 21498-08-8 56222-35-6
54-31-9 68-23-5 87-68-3 100-75-4 117-39-5 141-90-2 538-41-0 860-22-0 2578-75-8 7008-42-6 21638-36-8 56654-52-5
54-80-8 68-76-8 87-86-5 100-97-0 117-79-3 142-04-1 540-23-8 868-85-9 2611-82-7 7227-91-0 21884-44-6 56795-65-4
54-85-3 68-89-3 88-19-7 101-05-3 117-80-6 142-47-2 541-69-5 869-01-2 2629-59-6 7347-49-1 22571-95-5 56795-66-5
55-18-5 69-65-8 88-73-3 101-14-4 117-81-7 142-59-6 542-75-6 915-67-3 2698-41-1 7411-49-6 22760-18-5 56894-91-8
55-22-1 70-25-7 88-85-7 101-21-3 118-74-1 143-19-1 542-88-1 924-16-3 2757-90-6 7422-80-2 22839-47-0 57497-29-7
55-31-2 71-43-2 88-96-0 101-54-2 118-75-2 143-50-0 548-62-9 924-42-5 2783-94-0 7519-36-0 23031-25-6 57497-34-4
55-80-1 71-55-6 89-25-8 101-61-1 118-92-3 147-24-0 551-92-8 930-55-2 2784-94-3 7572-29-4 23135-22-0 57653-85-7
55-98-1 72-20-8 90-43-7 101-73-5 119-34-6 148-18-5 553-53-7 932-83-2 2832-40-8 7631-99-4 23255-69-8 60102-37-6
56-04-2 72-33-3 90-94-8 101-79-1 119-38-0 148-24-3 555-84-0 937-25-7 2835-39-4 7632-00-0 23950-58-5 60391-92-6
56-23-5 72-43-5 91-53-2 101-80-4 119-53-9 148-79-8 556-52-5 938-73-8 2921-88-2 7681-93-8 24382-04-5 60599-38-4
56-38-2 72-54-8 91-59-8 101-90-6 120-36-5 148-82-3 563-41-7 943-41-9 3012-65-5 7757-82-6 24554-26-5 61034-40-0
56-49-5 72-55-9 91-62-3 102-09-0 120-61-6 149-29-1 563-47-3 952-23-8 3031-51-4 7758-19-2 25081-31-6 61702-44-1
56-53-1 72-56-0 91-76-9 102-50-1 120-62-7 149-30-4 569-57-3 959-24-0 3068-88-0 8065-91-6 25168-26-7 63412-06-6
56-72-4 73-22-3 91-79-2 102-71-6 120-71-8 150-38-9 569-61-9 961-11-5 3096-50-2 10024-97-2 25843-45-2 63885-23-4
56-75-7 74-31-7 91-93-0 102-77-2 120-78-5 150-68-5 576-68-1 968-81-0 3148-73-0 10048-13-2 26049-68-3 63886-77-1
56-86-0 74-96-4 91-94-1 103-03-7 120-80-9 151-56-4 578-76-7 971-15-3 3165-93-3 10102-43-9 26049-69-4 64049-29-2
57-06-7 75-00-3 92-13-7 103-16-2 120-83-2 156-10-5 590-21-6 999-81-5 3276-41-3 10318-26-0 26049-70-7 65734-38-5
57-14-7 75-01-4 92-52-4 103-23-1 120-93-4 156-51-4 592-31-4 1011-73-0 3296-90-0 10473-70-8 26049-71-8 67730-10-3
57-39-6 75-07-0 92-55-7 103-33-3 121-14-2 156-62-7 593-60-2 1068-57-1 3458-22-8 10589-74-9 26541-51-5 67730-11-4
57-41-0 75-09-2 92-67-1 103-72-0 121-66-4 262-12-4 593-70-4 1072-53-3 3544-23-8 12663-46-6 26628-22-8 68107-26-6
57-43-2 75-21-8 92-69-3 103-90-2 121-69-7 271-89-6 597-25-1 1078-38-2 3546-10-9 12789-03-6 28314-03-6 69658-91-9
57-50-1 75-25-2 92-84-2 104-46-1 121-75-5 297-76-7 598-55-0 1114-71-2 3564-09-8 13010-07-6 28322-02-3 72254-58-1
57-55-6 75-27-4 92-87-5 105-11-3 121-88-0 297-78-9 598-64-1 1116-54-7 3567-69-9 13010-08-7 28754-68-9 73785-40-7
57-57-8 75-34-3 93-46-9 105-36-2 122-34-9 298-00-0 602-87-9 1119-68-2 3570-75-0 13010-10-1 29082-74-4 74920-78-8
57-74-9 75-35-4 93-72-1 105-55-5 122-42-9 298-18-0 607-35-2 1120-71-4 3688-53-7 13073-35-3 30310-80-6 75198-31-1
57-97-6 75-56-9 93-76-5 105-60-2 122-60-1 302-15-8 608-73-1 1133-64-8 3693-22-9 13171-21-6 30418-53-2 75411-83-5
58-08-2 75-88-7 94-11-1 105-85-5 122-66-7 302-22-7 609-20-1 1146-71-0 3761-53-3 13256-11-6 31873-81-1 75881-18-4
58-14-0 76-01-7 94-20-2 106-46-7 123-31-9 302-79-4 611-23-4 1150-37-4 3775-55-1 13366-73-9 32221-81-1 75881-20-8
58-89-9 76-44-8 94-26-8 106-47-8 123-33-1 303-34-4 611-32-5 1150-42-1 3778-73-2 13483-18-6 32607-00-4 75881-22-0
59-02-9 77-06-5 94-52-0 106-50-3 123-73-9 303-47-9 612-82-8 1156-19-0 3817-11-6 13552-44-8 32852-21-4 75896-33-2
59-05-2 77-65-6 94-58-6 106-87-6 123-91-1 305-03-3 613-50-3 1162-65-8 3851-16-9 13743-07-2 33229-34-4 76180-96-6
59-33-6 77-79-2 94-59-7 106-88-7 124-48-1 306-37-6 613-94-5 1163-19-5 3883-43-0 13752-51-7 33857-26-0 77337-54-3
59-35-8 77-83-8 94-75-7 106-89-8 124-64-1 309-00-2 614-00-6 1212-29-9 4075-79-0 13838-16-9 33868-17-6 82018-90-4
59-51-8 78-34-2 94-80-4 106-92-3 126-72-7 315-18-4 614-95-9 1241-27-6 4106-66-5 14026-03-0 34176-52-8 86451-37-8
59-67-6 78-42-2 95-06-7 106-93-4 126-85-2 315-22-0 615-28-1 1248-18-6 4164-28-7 15356-70-4 34522-69-5 88208-16-6
59-87-0 78-59-1 95-14-7 106-99-0 127-06-0 319-84-6 617-84-5 1453-82-3 4247-02-3 15481-70-6 34627-78-6 89911-78-4
59-88-1 78-87-5 95-33-0 107-06-2 127-18-4 320-67-2 619-17-0 1465-25-4 4342-03-4 15721-02-5 35449-36-6 89911-79-5
60-11-7 79-00-5 95-50-1 107-07-3 127-47-9 324-93-6 619-67-0 1508-45-8 4363-03-5 15879-93-3 36133-88-7 91308-69-9
60-13-9 79-01-6 95-74-9 107-13-1 127-69-5 330-54-1 621-64-7 1582-09-8 4463-22-3 15973-99-6 36702-44-0 91308-70-2
60-34-4 79-06-1 95-79-4 107-20-0 128-37-0 333-41-5 622-51-5 1596-84-5 4548-53-2 16071-86-6 37087-94-8 91308-71-3
60-35-5 79-11-8 95-80-7 107-30-2 128-44-9 363-17-7 624-18-0 1634-78-2 4553-89-3 16219-99-1 38434-77-4 92177-49-6
60-51-5 79-19-6 95-83-0 108-03-2 128-66-5 389-08-2 624-84-0 1701-77-5 4680-78-8 16301-26-1 38514-71-5 92177-50-9
60-56-0 79-34-5 96-09-3 108-05-4 129-15-7 398-32-3 625-89-8 1746-01-6 4812-22-0 16338-97-9 38571-73-2
60-57-1 79-44-7 96-12-8 108-30-5 131-01-1 434-13-9 628-02-4 1777-84-0 4998-76-9 16568-02-8 39156-41-7
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Appendix B. Fragments statistically associated with carcinogenicity or lackthereof(p<0.01)
Fragment Concordant Discordant
structurea observations observations Activity
C.**2C-C--C-*C.*C- 12 1 +
C.**2C-C--C-*C*C*C*C- 12 1 +
C**2C-C--C**5C-.C*C*C- 12 1 +
C**2-3C-.C-C**5C-.C- 12 1 +
C**2-3C-.C-C-*C*C*C- 12 1 +
C..--2C.C. 9 2
C**2C-C-*4S::.C*C- 9 2
C.-*2S::.C*C*C.*C- 9 2
C--2C.N--4N:C-C. 11 0 +
0--2C--C.=0 9 2
0--2C:.C-*C- 11 2
C~-*2C,C*C.*C-. 12 1 +
N--2-3N:C.C.=0 13 0 +
N--2-3N:C.C-C.. 9 0 +
C--2C.C.-C..-C 9 2
C.--2C.C.-C..-C 8 1
C--2C.C.-C.-C. 9 2
C.--2C..C..-C. 10 2
C--2-3C..C.C.-C. 10 2
C--2C.C..-C.. 9 2 2
C--2C...C-C.. 10 2
C-*2*3N.S-N- 12 1 +
S**2C-C.*N- 12 1 +
N**2C-.C.*S- 12 1 +
C--*2C0O- 9 0 +
C--2N..C: 11 0 +
C.--20.C:. 10 1
C--*2N::C*C*C--C-*C- 11 0 +
N**2C-.C--C-*C*C*C-. 13 0 +
C**2S-C--C-*C*C*C-. 11 0 +
C**2-3N-C-C-*C*C~ 12 1 +
0**2C-.C--C-*C- 11 0 +
0**2C-.C~-C-*N*C-. 10 0 +
C--2-30,C..C. 11 2
C--*2N,C*C*C--C-- 12 1 +
C--*2C.C.*C-. 8 1
O-C:. 9 1
C.--2C.C.-C..-C..-C. 6 0 _
C--2-3C..C..C-C. 8 0
C--2C:.C-C.. 10 1
0--2C:.C-*C-. 9 2
C~-*2CI,C*C-*5CI,C.*C- 10 2
N--2C..C. 7 0
C--20.C.=0 6 0
0--2C--C-C:. 6 0
C~-*20.C--Cl 9 2
C.--20,C:. 6 0
N--2C:.C-*C*C*C- 7 0
C:--20,C-*C*C- 6 0
C.--2C--C:. 7 0
In this list, fragments that are similar but not identical or imbedded one in the other
have not been eliminated. In few cases they could come from similar groups of
molecules.
aFragment coding: the fragment code is composed by a list of atoms and bonds. In
particular, each atom is followed by the list of appended bonds and bonds with
atoms following in the code. The first elements of such a list are the appended
bonds, i.e., the bonds that link the atom with another one not in the fragment; the
other elements are the bondswith atoms belonging tothe fragment.
The appended bonds are indicated bythe following symbols:
(.) single bond;
(:) double bond;
(-) aromatic and heteroaromatic bonds;
C) ionic bond.
Forexample, C.: is equal to -C=.
The remaining bonds, with atoms belonging to the fragment, are indicated bythe fol-
lowing symbols:
(-)single bonds;
I=) double bonds;
(*) aromatic and heteroaromatic bonds.
We have not described other bonds present in chemicals not appearing in Appendix
B. To simplify the bonding information, we have used a unique symbol to codify the
bonds involved in the main cyclic resonant structures (e.g., benzene, furan, thio-
phene). Each ofthe bonds ofthe second group may be followed by a number indicat-
ing the position in the fragment code ofthe second atom involved; if no number fol-
lows, then it is assumed thatthe bond is relevantto the immediatelyfollowing atom.
Note that the first atom in a fragment code is associated with the number zero, the
second with the number 1, and so on. Forexample, in C--2N..C,the first C is linked to
the N by a single bond and tothe last C with anothersingle bond. N has two append-
ed single bonds.
Finally, it must be noted that the bonds with hydrogen are not indicated (they
can be inferred from the valence ofthe atom), and a comma is simply used to sepa-
rate two atoms not separated by other symbols. For example, C.-*2CI,C*C-
*5CI,C.*C- correspondstothefragment below:
CIH
CH
Ci
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